|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.6001 USD | -3.86% |
|
-21.05% | -79.09% |
| 10-14 | Tempest Therapeutics, Inc. Announces Appointment of John W. Frederick as Director | CI |
| 10-07 | Sensorion: Louis J. Arcudi III appointed chief financial officer |  |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TPST | Delayed | |
CBOE
| TPST | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.8343 | 1.21 | 1.59 |
| Spread/Res. | -28.07% | -50.40% | -62.26% |
| Spread/Supp. | +0.35% | +20.72% | +26.68% |
| Support | 0.598 | 0.4971 | 0.4737 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TPST Stock
- Charts Tempest Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
